The Catholic University BIMA Grafting Study

计划入组 1,000 人 · 首次发布于 2012 年 5 月 8 日

Evaluating True PCR-negative Rate of Frontline Dasatinib in Early Chronic Phase CML for Therapeutic Harmonization

计划入组 102 人 · 首次发布于 2016 年 11 月 29 日

Facilitated Telemedicine in the Catholic Health System

计划入组 200 人 · 首次发布于 2024 年 7 月 3 日

N-aminoimidazole derivatives (Catholic University of Leuven)

PPARα/γ Agonist(University of Milan)

anti-VPAC1 antibodies (Catholic University of Leuven/ThromboGenics)

University of Milan

Italy

Catholic University of Korea

South Korea

The Catholic University Of Korea

South Korea

Blood Protein Signature Identified in Pediatric Long Covid, Opening Path for Diagnostic Test

Catholic Health and HICCC at NYP/Columbia Partner to Expand Cancer Clinical Trial Access Across Long Island

UPC Milan Revokes Remdesivir Patent for Lack of Inventive Step, Drawing Sharp Distinction Between Reasonable Expectation and Mere Hope of Success